Nitrofuran drugs beyond redox cycling: Evidence of Nitroreduction-independent cytotoxicity mechanism

Simple item page
dc.contributor.authorGallardo-Garrido, C.
dc.contributor.authorCho, Y.
dc.contributor.authorCortes-Rios, J.
dc.contributor.authorVasquez, D.
dc.contributor.authorPessoa-Mahana, C. D.
dc.contributor.authorAraya-Maturana, R.
dc.contributor.authorPessoa-Mahana, H.
dc.contributor.authorFaundez, M.
dc.date.accessioned2025-01-23T19:49:49Z
dc.date.available2025-01-23T19:49:49Z
dc.date.issued2020
dc.description.abstractNitrofurans (5-nitro-2-hydrazonylfuran as pharmacophore) are a group of widely used antimicrobial drugs but also associated to a variety of side effects. The molecular mechanisms that underlie the cytotoxic effects of nitrofuran drugs are not yet clearly understood. One-electron reduction of 5-nitro group by host enzymes and ROS production via redox cycling have been attributed as mechanisms of cell toxicity. However, the current evidence suggests that nitrofuran ROS generation by itself is uncapable to explain the whole toxic effects associated to nitrofuran consumption, proposing a nitro-reduction independent mechanism of toxicity.
dc.description.abstractIn the present work, a series of nitrated and non-nitrated derivatives of nitrofuran drugs were synthesized and evaluated in vitro for their cytotoxicity, ROS-producing capacity, effect on GSH-S-transferase and antibacterial activity.
dc.description.abstractOur studies showed that in human cells non-nitrated derivatives were less toxic than parental drugs but, unexpectedly preserved the ability to generate intracellular ROS in similar amounts to nitrofurans despite not entering into a redox cycle mechanism. In addition, some non-nitrated derivatives although being uncapable to generate ROS exhibited the highest cell toxicity among all derivatives. Inhibition of cytosolic glutathione-S-transferase activity by some derivatives was also observed. Finally, only nitrofuran derivatives displayed antibacterial effect.
dc.description.abstractResults suggest that the combined 2-hydrazonylfuran moiety, redox cycling of 5-nitrofuran, and inhibitory effects on antioxidant enzymes, would be finally responsible for the toxic effects of the studied nitrofurans on mammalian cells.
dc.fuente.origenWOS
dc.identifier.doi10.1016/j.taap.2020.115104
dc.identifier.eissn1096-0333
dc.identifier.issn0041-008X
dc.identifier.urihttps://doi.org/10.1016/j.taap.2020.115104
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/100522
dc.identifier.wosidWOS:000551512500017
dc.language.isoen
dc.revistaToxicology and applied pharmacology
dc.rightsacceso restringido
dc.subjectNitrofurans
dc.subjectCytotoxicity
dc.subjectReactive Oxygen Species
dc.subjectNitroreduction
dc.subjectHydrazone
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleNitrofuran drugs beyond redox cycling: Evidence of Nitroreduction-independent cytotoxicity mechanism
dc.typeartículo
dc.volumen401
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files
Collections
Artículos de revistas